当前位置:主页 > 医学论文 > 泌尿论文 >

糖肾方联合贝前列素钠影响糖尿病肾病患者炎症因子及安全性的临床观察

发布时间:2018-03-22 00:15

  本文选题:糖肾方 切入点:贝前列素钠 出处:《中国实验方剂学杂志》2017年21期  论文类型:期刊论文


【摘要】:目的:观察糖肾方联合贝前列素钠对糖尿病肾病患者(DKD)炎症因子的影响及安全性。方法:单纯应用糖肾方(中药组)、贝前列素钠(西药组)与两者联合应用(合用组)进行随机平行对照研究,观察各组患者给药前后临床疗效、中医证候积分、空腹血糖(FBG)、尿蛋白排泄率(UAER)及相关炎性细胞因子转化生长因子(TGF)-β1,肿瘤坏死因子(TNF)-α及白细胞介素(IL)-18等的变化。结果:与治疗前比较,各组治疗后各项指标均降低;与西药组比较,中药组患者FBG水平明显降低(P0.05);与中药组比较,西药组患者IL-18水平明显降低(P0.05);与中药组、西药组比较,合用组患者临床总有效率升高(P0.05),合用组患者的肾气虚相关症状(腰膝酸软、口干不欲饮)积分,FBG水平,UAER水平以及炎症因子水平均明显降低(P0.05);与西药组比较,合用组患者脾气虚相关症状(纳差乏力、肢体浮肿)积分明显降低(P0.05)。3组患者研究过程中均未发现严重不良反应。结论:糖肾方与贝前列素钠联用,可提高降低患者尿蛋白,改善炎症状态的作用,对临床期DKD有较好的治疗效果。
[Abstract]:Objective: to observe the effect and safety of Tangshen recipe combined with beprost sodium on inflammatory factors of diabetic nephropathy patients with DKD. Methods: Tangshen recipe (traditional Chinese medicine group), beprostol sodium (western medicine group) and combined therapy (combined with both) were used. In a randomized, parallel controlled study, Observe the clinical effect before and after administration of drugs, TCM syndrome score, The changes of FBGG, urinary protein excretion rate (UAER-UAER), TGF- 尾 _ 1, TNF- 伪 and IL-IL-18, and so on. Results: compared with those before and after treatment, the indexes of each group were decreased, and those of western medicine group were lower than those of western medicine group, and the changes of TGF- 尾 1, TNF- 伪 and IL-IL-18 in each group were lower than those before treatment, and compared with those in western medicine group. Compared with the traditional Chinese medicine group and the western medicine group, the level of IL-18 in the western medicine group was significantly lower than that in the traditional Chinese medicine group and the western medicine group. Compared with the traditional Chinese medicine group and the western medicine group, the total clinical effective rate of the combined group was higher than that of the traditional Chinese medicine group and the western medicine group. The FBG level, UAER level and inflammatory factor level were significantly lower than those in the western medicine group, and compared with the western medicine group, the symptoms related to spleen qi deficiency (anorexia) in the combined group were significantly lower than those in the western medicine group. Conclusion: the combination of Tangshen recipe and beprostol sodium can improve the effect of reducing urine protein and improving inflammatory state in patients with lower urinary protein and lower inflammatory state, and no serious adverse reactions were found in the study of P0.050.Conclusion: the combination of Tangshen recipe and beprostol sodium can increase the level of urinary protein and improve the inflammatory state of the patients. It has good therapeutic effect on DKD in clinical stage.
【作者单位】: 上海中医药大学附属第七人民医院;
【基金】:上海市卫生和计划生育委员会中医药科研基金项目(2014LP032A);上海市卫生和计划生育委员会科研计划项目(201440543) 上海市科学技术委员会科研计划项目(15401930600)
【分类号】:R587.2;R692.9

【相似文献】

相关期刊论文 前10条

1 罗卓章;;贝前列素钠降低早期糖尿病肾病蛋白尿的临床研究[J];白求恩医学杂志;2014年04期

2 冯晓云;张兰予;邹俊杰;刘志民;;贝前列素钠对糖尿病大鼠坐骨神经病变的保护作用[J];药学服务与研究;2012年02期

3 马志明;杜文丽;王春霞;;贝前列素钠降低糖尿病肾病蛋白尿的效果观察[J];大家健康(学术版);2013年20期

4 张力心;刘阳;韦晓娣;魏畅;;贝前列素钠片治疗早期糖尿病肾病的疗效观察[J];中国伤残医学;2013年04期

5 黄娟;张韶英;段晓宇;管斯斯;;贝前列素钠治疗对早期糖尿病肾病患者血清胱抑素C及尿微量清蛋白的影响[J];中国全科医学;2012年21期

6 齐志华;吴冬云;朱贵忠;;贝前列素钠降低糖尿病肾病蛋白尿的效果观察[J];实用医学杂志;2011年22期

7 罗徐;;贝前列素钠联合糖皮质激素治疗狼疮肾炎患者蛋白尿和血尿的临床观察[J];湖南中医药大学学报;2014年06期

8 黄文权;陈俏洁;陈聪;;贝前列素联合维生素E治疗2型糖尿病合并下肢血管病变对防止心脑血管疾病发生的研究[J];中国医药科学;2014年13期

9 周卫华;张玉娜;刘桂红;;贝前列素钠对糖尿病肾病尿白蛋白/肌酐比值及血管内皮功能的影响[J];疑难病杂志;2013年05期

10 罗远标;黄少珍;李华友;;贝前列素钠联合贝那普利对糖尿病肾病的尿微量白蛋白和hs-CRP、TNF-α的影响[J];实用医学杂志;2014年10期

相关会议论文 前2条

1 王爱红;程玉霞;牛文芳;许樟荣;;贝前列素钠治疗糖尿病合并下肢动脉病变的随机对照研究[A];中华医学会第十次全国内分泌学学术会议论文汇编[C];2011年

2 王晓露;李凡;曾芙蓉;高俊杰;钟倩;李丽颖;;贝前列素钠治疗糖尿病周围神经病变疗效及安全性观察[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年

相关博士学位论文 前1条

1 张倩;贝前列素钠对高糖损伤大鼠系膜细胞的保护作用及其机制研究[D];南方医科大学;2013年



本文编号:1646200

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mjlw/1646200.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户7f38c***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com